Suppr超能文献

1989 - 1991年美国局部用皮质类固醇的处方模式。

The pattern of topical corticosteroid prescribing in the United States, 1989-1991.

作者信息

Stern R S

机构信息

Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, MA 02215, USA.

出版信息

J Am Acad Dermatol. 1996 Aug;35(2 Pt 1):183-6. doi: 10.1016/s0190-9622(96)90319-9.

Abstract

BACKGROUND

Topical corticosteroids are widely used in the treatment of skin diseases. These preparations vary greatly in potency. They are available in both brand name and generic formulations, as well as in combination products.

OBJECTIVE

Our purpose was to determine the pattern of topical corticosteroids prescribing in the United States and the relation of patient and prescriber attributes to the type of corticosteroid preparation prescribed.

METHODS

Data from the 1989 to 1991 National Ambulatory Medical Care Survey were used to estimate the number of visits with a topical corticosteroid preparation prescribed and to identify prescribers with specific characteristics.

RESULTS

In the United States, topical corticosteroids are prescribed or recommended at an average of 14 million visits per year to office-based health practitioners. Forty percent of these visits were to dermatologists. Dermatologists were 3.9 times more likely to prescribe very high potency steroids than were other physicians. Physicians other than dermatologists were 8.4 times more likely than dermatologists to prescribe combination agents containing moderate- or high-potency topical corticosteroids and an antiinfective agent.

CONCLUSION

The pattern of topical corticosteroid prescribing is substantially different for dermatologists and other physicians. These differences may reflect differences in severity or complexity of the disease or differences in prescribing habits. The importance of these differences to the outcome of treated patients is not established.

摘要

背景

外用皮质类固醇广泛用于皮肤病治疗。这些制剂的效力差异很大。它们有品牌名和通用名剂型,也有复方产品。

目的

我们的目的是确定美国外用皮质类固醇的处方模式以及患者和开处方者的属性与所开皮质类固醇制剂类型的关系。

方法

使用1989年至1991年国家门诊医疗调查的数据来估计开具外用皮质类固醇制剂的就诊次数,并识别具有特定特征的开处方者。

结果

在美国,每年平均有1400万次就诊时向门诊医疗从业者开具或推荐外用皮质类固醇。其中40%的就诊是看皮肤科医生。皮肤科医生开具超强效类固醇的可能性是其他医生的3.9倍。皮肤科以外的医生开具含中效或高效外用皮质类固醇和抗感染剂复方制剂的可能性是皮肤科医生的8.4倍。

结论

皮肤科医生和其他医生在外用皮质类固醇的处方模式上有很大差异。这些差异可能反映了疾病严重程度或复杂性的差异或处方习惯的差异。这些差异对接受治疗患者的结局的重要性尚未确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验